Clinical Trial

Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer

Name: Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer — clinical trial record (NCT06562920)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Neoadjuvant

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To explore the effectiveness and safety of adebrelimab combined with chemotherapy and concurrent SBRT for 3 cycles of neoadjuvant treatment followed by surgery in T1-3N0-1M0 limited-stage SCLC

Trial Details

NCT Number	NCT06562920
Lead Sponsor	Zhejiang Cancer Hospital
Conditions	Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer
Enrollment	20 participants
Start Date	2024-07-24
Primary Completion	2027-07-31 (estimated)
Study Completion	2028-07-31 (estimated)
Updated on ClinicalTrials.gov	2024-08-20